Summary
At low pH values (around 6), porcine pancreatic β-kallikrein B attacks at first the C-terminal ARg bond of the kinin moiety in bovine HMW kininogen. Arg-cleaved kininogen accumulates as an intermediate in the solution. Kallidin is released by cleavage of the aminoterminal Met-Lys bond in a second step. At pH values between 7.6 and 9, however, Arg-cleaved kininogen does not occur as a free intermediate. The participation as a (free, not only enzyme-bound) intermediate of Arg-cleaved kininogen in a short-lived especially reactive conformation or of Met-cleaved kininogen is also unlikely. Probably, both the Met and the Arg bonds are hydrolyzed in one enzyme-substrate complex which does not dissociate between these two events.
Kinetic constants for the release of kallidin from native single-chain HMW kininogen and from Arg-cleaved kininogen (even if this Arg residue is removed) remarkably have the same values. Evidently, the rate of the reaction is determined by steps leading to the hydrolysis of the Met bond. As the state of the C-terminal Arg residue has no influence, the efficient cleavage of the Met bond by tissue kallirkein is probably not due to some strain in the kininogen molecule in the region of this bond. As modification of Arg residues of kininogen prevents cleavage also of the Met bond, some Arg residue(s) appear(s) to play a crucial role in this process. Kcat/Km (1.4 x 106 M-1 sec-1 at pH 9, 25° C) is very high for a proteolytic reaction, mainly because of the low value of (0.6 μM). Kcat/Km for the hydrolysis of the Met bond in kininogen is 3 500 times higher than in the peptide Ser-Leu-Met-Lys-brady-kinin with a partial kininogen sequence. Important interactions with the enzyme thus occur in regions of the kininogen molecule outside this sequence. Kcat/Km for the hydrolysis of the Arg bond in the kininogen peptide Pro-Phe-Arg-Ser-Val-Gln is also 14 times lower than this constant for the release of kallidin from kininogen, but kcat is 6 times higher. This can explain why cleavage of the Arg bond is not reflected in the kinetic constants of single-chain kininogen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
E. Habermann, Strukturaufklarung kininliefernder Peptide aus Rinderserum-Kininogen, Arch. Exp. Path. Pharmak., 253: 474–483 (1966).
Y. N. Han, H. Kato, S. Iwanaga, and T. Suzuki, Bovine plasma high molecular weight kininogen: The amino acid sequence of fragment 1 (glycopeptide) released by the action of plasma kallikrein and its location in the precursor protein, FEBS Lett., 63: 197 – 200 (1976).
F. Fiedler and G. Leysath, Substrate specificity of porcine pancreatic kallikrein, Adv. Exp. Med. Biol., 120A: 261–271 (1979).
F. Fiedler, Enzymology of porcine tissue kallikrein, Adv. Exp. Med. Biol., 156A: 263 – 274 (1983).
F. Fiedler, E. Fink, H. Tschesche, and H. Fritz, Porcine glandular kallikreins, Methods Enzymol., 80: 493 – 532 (1981).
C. Kutzbach and G. Schmidt-Kastner, Kallikrein from pig pancreas: Purification, separation of components A and B, and crystallization, Hoppe-Seyler1s Z. Physiol. Chem., 353: 1099 – 1106 (1972).
M. Komiya, H. Kato, and T. Suzuki, Bovine plasma kininogens. I. Further purification of high molecular weight kininogen and its physiocochemical properties, J. Biochem. (Tokyo), 76: 811 – 822 (1974).
T. Shimada, T. Sugo, H. Kato, and S. Iwanaga, A method for preparation of a single chain high-molecular-weight (HMW) kininogen from bovine plasma, J. Biochem. (Tokyo), 92: 679 - 688 (1982).
K. Weber and M. Osborn, The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis, J. Biol. Chem., 244: 4406–4412 (1969).
W. Miiller-Esterl, G. Rauth, H. Fritz, F. Lottspeich, and A. Henschen, Human kininogens, in: “Kininogenases-Kallikrein 6, ” G. L. Haberland, J. W. Rohen, H. Fritz, and P. Huber, eds., F. K. Schattauer Verlag (1983).
K. Mori, W. Sakamoto, and S. Nagasawa, Studies on human high molecular eight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein, J. Biochem. (Tokyo), 90: 503–509 (1981).
E. S. Prado, C. A. M. Sampaio, M. S. Araujo-Viel, and R. C. R. Stella, Characterization of horse urinary kallikrein, in: “Recent Progress on Kinins (Agents and Actions Supplements 9),” H. Fritz, G. Dietze, F. Fiedler, and G. L. Haberland, eds., Birkhauser Verlag (1982).
J. V. Pierce and J. A. Guimaraes, Further characterization of highly purified human plasma kininogens, in: “Chemistry and Biology of the Kallikrein-Kinin System in Health and Disease,” J. J. Pisano and K. F. Austen, eds., U. S. Government Printing Office, without year (1976).
M. Maier, K. F. Austen, and J. Spragg, Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens, Biochemistry, 80: 3928 – 3932 (1983).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Fiedler, F., Hinz, H., Lottspeich, F. (1986). Individual Reaction Steps in the Release of Kallidin from Kininogen by Tissue Kallikrein. In: Greenbaum, L.M., Margolius, H.S. (eds) Kinins IV. Advances in Experimental Medicine and Biology, vol 198A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5143-6_39
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5143-6_39
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5145-0
Online ISBN: 978-1-4684-5143-6
eBook Packages: Springer Book Archive